期刊文献+

胃肠道间质瘤32例的临床研究

Clinical research on 32 cases of gastrointestinal stromal tumor
原文传递
导出
摘要 目的 通过研究32例胃肠道间质瘤的临床病理特点,探讨胃肠道间质瘤的预后影响因素.方法 回顾性分析2007年5月-2013年4月接受手术治疗并经病理证实的32例胃肠道间质瘤的临床资料,统计学分析影响其预后的因素.结果 32例患者,2年总体生存率为85.3%,2年无进展生存率为79.2%.影响胃肠道间质瘤预后的因素包括:肿瘤大小、远处转移、核分裂像、NIH危险度分级.结论 NIH分级、远处转移是影响胃肠道间质瘤术后生存的危险因素. Objective Analyzed 32 cases of gastrointestinal stromal tumors(GIST) patients,to analysis the clinical and pathological characteristics of gastrointestinal stromal tumors of the stomach and explore associated prognostic factors.Methods Thirty-two GIST patients confirmed pathologically were included from May,2007 to April,2013.Their clinical records were retrospectively analyzed.Results Of the 32 GIST patients,the overall survival (OS) is 85.3% for the second year.The progression free survival (PFS) is 79.2% for the second year,respectively.Univariate survival analysis showed that OS and PFS have significant association with tumor size,metastasis,mitotic index and NIH risk group.Conclusions Metastasis and NIH risk group both are potential prognostic factor for gastric GIST.
作者 李伟
出处 《国际外科学杂志》 2013年第10期669-671,共3页 International Journal of Surgery
关键词 胃间质瘤 外科手术 预后 肿瘤 Gastrointestinal stromal tumors Surgical procedures, operative Prognosis Neoplasms
  • 相关文献

参考文献13

  • 1陈永生,齐莉.胃肠管间质瘤生物学行为相关研究新进展[J].国际外科学杂志,2008,35(7):486-489.
  • 2Corless CL,Fletcher JA,Heinrich MC.Biology of gastrointestinal stromal tumors[J].J Clin Oncol,2004,22(18):3813-3825.
  • 3陈文超,张谢夫,赵春临,等.胃肠间质瘤基因突变和分子靶向治疗相关研究进展[J].国际外科杂志,2008,35(5):333-335.
  • 4贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 5Joensuu H.Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J].Hum Pathol,2008,39 (10):1411-1419.
  • 6Fletcher CD,Berman JJ,Corless C,et al.Diagnosis of gastrointestinal stromal tumors:A consensus approach[J].Hum Pathol,2002,33 (5):459-465.
  • 7何纯刚,陈利生,李君,张森,梁君林,曹云飞.胃肠道外间质瘤的临床特征、治疗与预后[J].中华普通外科杂志,2007,22(8):579-581. 被引量:14
  • 8Casali PG,Jost L,Reichardt P,et al.Gastrointestinal stromal tumours:ESMO clinical recommendations for diagnosis,treatment and follow-up[J].Ann Oncol,2009,20(Suppl 4):64-67.
  • 9Badalamenti G,Rodolico V,Fulfaro F,et al.Gastrointestinal stromal tumors (GISTs):focus on histopathological diagnosis and biomolecular features[J].Ann Oncol,2007,18(Suppl 6):Vi136-140.
  • 10Blesius A,Cassier PA,Bertucci F,et al.Neoadjuvant imatinib in patients with locally advanced GIST in the prospective BFRI4 trial[J].BMC Concer,2011,11:72.

二级参考文献28

  • 1贺慧颖,项一宁,李燕,钟镐镐,吴秉铨,郑杰.胃肠道间质瘤60例中c-kit和PDGFRA基因突变的检测[J].北京大学学报(医学版),2005,37(3):320-324. 被引量:10
  • 2Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs) : a review. Eur J Cancer,2002, 38 : S39 -S51.
  • 3Joensuu H, Kindblom LG. Gastrointestinal stromal tumors-a review.Acta Orthop Stand Suppl, 2004, 75:62-71.
  • 4Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science, 2003, 299:708 -710.
  • 5Corless CL, Schroeder A, Griffith D, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency,, spectrum and in vitro sensitivity to imatinib. J Clin Oncol, 2005, 23:5357-5364.
  • 6Debiec-Rychter M, Dumez H, Judson I, et al. Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase Ⅰ and Ⅱ studies of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2004,40:689-695.
  • 7Noma K, Naomoto Y, Gunduz M, et al. Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines.Oncol Rep, 2005, 14:645-650.
  • 8Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol,2002, 33:459-465.
  • 9Lasota J, Jasinski M, Satlomo-Rikala M, et al. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol, 1999, 154:53-60.
  • 10Kim TW, Lee H, Kang YK, et al. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res, 2004, 10:3076-3081.

共引文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部